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Bronchocentric granulomatosis in asthmatic patients has been generally considered to be associated with
allergic bronchopulmonary aspergillosis and represent a histopathologic manifestation of fungal hy-
persensitivity. Here we report a case of an idiopathic bronchocentric granulomatosis in a 17-year-old
man with a history of asthma. He was admitted to the hospital with a fever and cough, and a chest CT
scan showed peribronchial consolidation in the pulmonary parenchyma, which was unresponsive to
antibiotic therapy. The pathological ﬁndings obtained by video-assisted thoracoscopic lung biopsy
revealed necrotizing granulomatous inﬂammation centered on bronchi and bronchioles and there was
no evidence of fungal colonization, resulting in a diagnosis of idiopathic bronchocentric granulomatosis.
Systemic corticosteroid therapy led to clinical and radiological recovery. Physicians should take into
account the possibility of the idiopathic process in bronchocentric granulomatosis of asthmatic patients.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bronchocentric granulomatosis (BCG) is a histological diagnosis
characterized by a granuloma formation and necrosis affecting
bronchi and bronchioles [1,2]. BCG has been described in associa-
tion with asthma and allergic bronchopulmonary aspergillosis
(ABPA), whereas the cases of non-asthmatic patients with BCG are
usually idiopathic [2,3]. Here, we report a case of idiopathic BCG in
an asthmatic adolescent without accompanying pathological
aspergillus infection.2. Case report
A 17 year-old man presented with fever and non-productive
cough lasting for more than 1 week. Although he had a history of
asthma in childhood, his asthmatic symptoms had remitted and he
used a short-acting bronchodilator only occasionally in the last few
years. Upon examination, his oxygen saturation was 98% on room
air and no crackles nor wheezes were auscultated over the chest.
Laboratory investigation showed an increased white blood cell
count of 13890/mm3 with 82.9% neutrophils and 0.4% eosinophils.y, Graduate School of Medi-
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Serum IgE level was slightly elevated to 633 IU/ml. A high resolution
CT scan demonstrated focal consolidation in the left lower lobe
without the evidence of central bronchiectasis ormucoid impaction
(Fig.1A).We diagnosed as community acquired bronchopneumonia
and oral azithromycin was administrated as antibiotic therapy.
However, he was admitted to our hospital 6 days later, suffering
from prolonged fever. Rapid inﬂuenza antigen test was negative for
inﬂuenza A and B. The galactomannan antigen of Aspergillus, an-
tibodies of mycoplasma and human-immunodeﬁciency virus were
negative. Serological tests for antinuclear cytoplasmic antibody and
rheumatoid factor were also negative. The levels of angiotensin-
converting enzyme, (1e3)-b-D glucan were normal. The level of
soluble interleukin-2 receptor in serum was slightly elevated to
613 U/ml.
He was started on an intravenous infusion of sulbactam/
ampicillin for the ﬁrst three days followed by administration of
meropenem plus clindamycin. However, his fever persisted and
the re-evaluation of the CT scan on day 4 after hospitalization
revealed the exacerbation of left lower lobe consolidation, and
new inﬁltrative opacity appeared in the right upper lobe (Fig. 1B).
Bronchoscopy results including mycobacterial and fungal culture
were negative and revealed no malignancy. He then underwent
video-assisted thoracoscopic lung biopsy of the right upper lobe
on day 11, because we considered the possibility of lymphomatoid
granulomatosis, malignant lymphoma and granulomatosis withnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. (A) A chest CT scan on admission. Focal consolidation in the left lower lobe is conﬁrmed. (B) A chest CT scan on day 4 after hospitalization. Appearance of consolidation in the
right upper lobe and the deterioration of the lung shadow in left lower lobe can be seen.
Fig. 2. Histopathologic examination (Hematoxylin and eosin stains) of lung biopsy specimen. (A) The bronchiolar mucosa is partially replaced by necrotizing granulomatous
inﬂammation. The cellular inﬁltrate is present in the lumen and the peribronchiolar lesion. (B) Higher magniﬁcation photomicrograph shows granulomatous inﬂammation and
remnant of respiratory epithelium.
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pathology of the resected specimen revealed necrotizing granu-
lomatous inﬂammation centered on bronchi and bronchioles
(Fig. 2). Histiocytes, neutrophils and lymphocytes inﬁltrated in the
affected airways, but eosinophils were hardly observed. The Gro-
cott and periodic acid-Schiff (PAS) stains showed no fungal ele-
ments and Ziehl-Neelsen stain was also negative. The pathology
was diagnostic of BCG, resulting in a diagnosis of idiopathic BCG
based on no obvious evidence of the underlying disease. He was
prescribed oral prednisolone 30 mg daily with rapid resolution of
the fever. The improvement of radiograph ﬁndings also conﬁrmed
and oral steroids were gradually tapered. He had remained free of
relapse for six months after corticosteroid withdrawal.
3. Discussion
Katzenstein et al. described two patterns of BCG based on the
presence or absence of asthma [3]. Approximately half of all cases
are related to asthma and the prevalence appears to be increased in
younger age. Patients in this group generally manifest with pul-
monary complaints such as cough, dyspnea and wheezing. BCG in
asthmatic patients has been regarded as a form of ABPA and a hy-
perimmune response to colonizing fungi in the airway [3e5]. On
the other hand, non-asthmatic patients with BCG tend to be older
and less symptomatic. This group lacks evidence of fungal hyper-
sensitivity and is considered to be generally idiopathic, although it
has been reported to be associated with numerous diseases such as
rheumatoid arthritis, granulomatosis with polyangiitis, pulmonary
echinococcosis, and mycobacterial/fungal infection [5].Our patient had asthma in adolescence and developed chest
symptoms in onset, which typically presents in the asthmatic group
with BCG. However, we considered that this case differs from the
condition of ABPA, because fungal hyphae and tissue eosinophilia
were not identiﬁed in the involved airways of lung biopsy specimen
[3,6]. Furthermore, we were unable to determine the etiology of
BCG other than fungal infection. This case of BCG is idiopathic in an
asthmatic patient and extremely rare condition. We speculate that
there would be excess immunoreactions with unidentiﬁed exoge-
nous agents, because the clinical course was rapidly progressive
and there was no clear evidence of the underlying disease.
Corticosteroids are generally effective for BCG, although some
cases require long-term therapy due to recurrent or persistent
disease [3,4]. Our case was successfully treated with corticosteroid
monotherapy. It is very important to search the underlying condi-
tion that is associated with BCG before starting to administer cor-
ticosteroids. In particular, ABPA is recommended to administer
antifungal agent with corticosteroids [7e9]. In this case, lung bi-
opsy by video-assisted thoracoscopy helped to exclude the possi-
bility of fungal infection, and avoid unnecessary administration of
antifungal agents. We consider that BCG in asthmatic patients may
occur in not only fungal hypersensitivity but also idiopathic process
without fungal infection.
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